Northeast Pharmaceutical Group Co Ltd (000597) — Cash Flow Quality Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Quality Index of 6.30x as of September 2025. Operating cash flow of CN¥274.09 Million exceeds net income of CN¥43.52 Million, indicating high earnings quality where cash backs reported profits. Explore how well can Northeast Pharmaceutical Group Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Northeast Pharmaceutical Group Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Northeast Pharmaceutical Group Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Northeast Pharmaceutical Group Co Ltd.
Annual Cash Flow Quality Index for Northeast Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Northeast Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.25x | CN¥1.11 Billion | CN¥260.07 Million | ▲ +129.8% |
| 2024 | 1.85x | CN¥758.76 Million | CN¥409.85 Million | ▲ +13.1% |
| 2023 | 1.64x | CN¥586.75 Million | CN¥358.46 Million | ▼ -47.3% |
| 2022 | 3.10x | CN¥1.11 Billion | CN¥357.05 Million | ▼ -60.3% |
| 2021 | 7.82x | CN¥746.51 Million | CN¥95.44 Million | ▼ -85.2% |
| 2020 | 52.73x | CN¥570.92 Million | CN¥10.83 Million | ▲ +2448.8% |
| 2019 | 2.07x | CN¥352.60 Million | CN¥170.44 Million | ▲ +46.1% |
| 2018 | 1.42x | CN¥285.09 Million | CN¥201.37 Million | ▲ +143.3% |
| 2017 | -3.27x | CN¥-301.20 Million | CN¥92.06 Million | ▼ -122.4% |
| 2016 | 14.60x | CN¥384.51 Million | CN¥26.35 Million | ▲ +2503.4% |
| 2014 | 0.56x | CN¥46.99 Million | CN¥83.82 Million | ▼ -92.1% |
| 2012 | 7.05x | CN¥86.09 Million | CN¥12.21 Million | ▲ +57.8% |
| 2010 | 4.47x | CN¥255.96 Million | CN¥57.27 Million | ▲ +245.5% |
| 2009 | 1.29x | CN¥615.91 Million | CN¥476.08 Million | ▼ -34.7% |
| 2008 | 1.98x | CN¥709.03 Million | CN¥357.94 Million | ▼ -53.1% |
| 2007 | 4.23x | CN¥198.56 Million | CN¥46.99 Million | ▲ +178.2% |
| 2006 | -5.40x | CN¥-106.00 Million | CN¥19.63 Million | ▼ -164.7% |
| 2005 | 8.34x | CN¥111.40 Million | CN¥13.35 Million | ▼ -67.9% |
| 2004 | 25.96x | CN¥211.06 Million | CN¥8.13 Million | ▼ -2.3% |
| 2003 | 26.57x | CN¥230.08 Million | CN¥8.66 Million | ▲ +72.0% |
| 2002 | 15.45x | CN¥157.41 Million | CN¥10.19 Million | ▲ +98.1% |
| 2001 | 7.80x | CN¥78.84 Million | CN¥10.11 Million | ▲ +522.4% |
| 2000 | 1.25x | CN¥36.13 Million | CN¥28.84 Million | ▼ -0.5% |
| 1999 | 1.26x | CN¥54.62 Million | CN¥43.38 Million | ▲ +1233.2% |
| 1998 | -0.11x | CN¥-7.59 Million | CN¥68.35 Million | — |